Prediction of improved antimalarial chemoprevention with weekly dosing of dihydroartemisinin-piperaquine.
Intermittent preventive treatment (IPT) is used to reduce malaria morbidity and mortality, especially in vulnerable groups such as children and pregnant women. IPT with the fixed dose combination of piperaquine (PQ) and dihydroartemisinin (DHA) is being evaluated as a potential mass treatment to con...
Asıl Yazarlar: | Permala, J, Tarning, J, Nosten, F, White, N, Karlsson, M, Bergstrand, M |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
American Society for Microbiology
2017
|
Benzer Materyaller
-
Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
Yazar:: Chotsiri, P, ve diğerleri
Baskı/Yayın Bilgisi: (2019) -
Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
Yazar:: Palang Chotsiri, ve diğerleri
Baskı/Yayın Bilgisi: (2019-01-01) -
Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention.
Yazar:: Bergstrand, M, ve diğerleri
Baskı/Yayın Bilgisi: (2014) -
Efficacy and safety of dihydroartemisinin-piperaquine.
Yazar:: Myint, H, ve diğerleri
Baskı/Yayın Bilgisi: (2007) -
Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria
Yazar:: Lwin, K, ve diğerleri
Baskı/Yayın Bilgisi: (2012)